<?xml version="1.0" encoding="UTF-8"?>
<document id="DrugDDI.d214" origId="Ergotamine"><sentence id="DrugDDI.d214.s0" origId="s0" text="The effects of ERGOMAR may be potentiated by triacetyloleandomycin which inhibits the metabolism of ergotamine."><entity id="DrugDDI.d214.s0.e0" origId="s0.p1" charOffset="15-22" type="drug" text="ERGOMAR"/><entity id="DrugDDI.d214.s0.e1" origId="s0.p5" charOffset="45-66" type="drug" text="triacetyloleandomycin"/><entity id="DrugDDI.d214.s0.e2" origId="s0.p9" charOffset="100-110" type="drug" text="ergotamine"/><pair id="DrugDDI.d214.s0.p0" e1="DrugDDI.d214.s0.e0" e2="DrugDDI.d214.s0.e1" interaction="true"/><pair id="DrugDDI.d214.s0.p1" e1="DrugDDI.d214.s0.e0" e2="DrugDDI.d214.s0.e2" interaction="false"/><pair id="DrugDDI.d214.s0.p2" e1="DrugDDI.d214.s0.e1" e2="DrugDDI.d214.s0.e2" interaction="false"/></sentence><sentence id="DrugDDI.d214.s1" origId="s1" text="The pressor effects of ERGOMAR and other vasoconstrictor drugs can combine to cause dangerous hypertension."><entity id="DrugDDI.d214.s1.e0" origId="s1.p10" charOffset="4-19" type="drug" text="pressor effects"/><entity id="DrugDDI.d214.s1.e1" origId="s1.p11" charOffset="23-30" type="drug" text="ERGOMAR"/><entity id="DrugDDI.d214.s1.e2" origId="s1.p13" charOffset="41-62" type="drug" text="vasoconstrictor drugs"/><pair id="DrugDDI.d214.s1.p0" e1="DrugDDI.d214.s1.e0" e2="DrugDDI.d214.s1.e1" interaction="false"/><pair id="DrugDDI.d214.s1.p1" e1="DrugDDI.d214.s1.e0" e2="DrugDDI.d214.s1.e2" interaction="false"/><pair id="DrugDDI.d214.s1.p2" e1="DrugDDI.d214.s1.e1" e2="DrugDDI.d214.s1.e2" interaction="true"/></sentence></document>